These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 36449303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy?
    Wang Z, Xiang J, Gui Z, Qin Y, Sun W, Huang J, He L, Dong W, Zhang D, Zhang T, Shao L, Lv C, Zhang P, Zhang H.
    Endocr Pract; 2020 Oct; 26(10):1085-1092. PubMed ID: 33471710
    [Abstract] [Full Text] [Related]

  • 3. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K.
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
    Xu S, Huang H, Dong H, Wang X, Xu Z, Liu S, Liu J.
    BMC Cancer; 2023 Sep 18; 23(1):880. PubMed ID: 37723469
    [Abstract] [Full Text] [Related]

  • 6. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J, Zhang Z, Huang H, Xu S, Liu Y, Liu S, Wang X, Xu Z.
    Oral Oncol; 2019 Mar 18; 90():17-22. PubMed ID: 30846171
    [Abstract] [Full Text] [Related]

  • 7. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
    Zhao H, Gong Y.
    Front Endocrinol (Lausanne); 2022 Mar 18; 13():960682. PubMed ID: 36034423
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of surgical strategy for pediatric papillary thyroid carcinoma with low-intermediate risk].
    Zhao L, Li H, He YY, Wang K, Wang J, Yan DG, Ni S, Zhu YM, Liu SY.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec 07; 57(12):1396-1402. PubMed ID: 36707942
    [Abstract] [Full Text] [Related]

  • 9. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW, Qu Z, Qin AC, Pan H, Ye J, Jiang Y.
    Eur J Surg Oncol; 2020 Oct 07; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound.
    Xu S, Huang H, Xian K, Wang X, Xu Z, Liu S, Liu J.
    Endocrine; 2024 Oct 07; 86(1):276-283. PubMed ID: 38703328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B, Qiang W, Wenqi Z, Tianyu Y, Lina Z, Bin J.
    Nucl Med Commun; 2017 Dec 07; 38(12):1036-1040. PubMed ID: 28953211
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
    Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA.
    Ann Surg; 2014 Oct 07; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
    Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A.
    World J Surg; 2012 Jun 07; 36(6):1274-8. PubMed ID: 22270990
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
    Papachristos A, Do K, Tsang VH, Sywak M, Gill AJ, Sidhu S, Clifton-Bligh RJ, Glover A, Gild ML.
    Thyroid; 2022 Sep 07; 32(9):1086-1093. PubMed ID: 35703333
    [Abstract] [Full Text] [Related]

  • 19. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
    Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS.
    Endocr Relat Cancer; 2016 May 07; 23(5):367-76. PubMed ID: 26917553
    [Abstract] [Full Text] [Related]

  • 20. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS, Joshi N, Sharrett J, Rao S, Shah A, Scharpf J, Burkey B, Lamarre ED, Prendes B, Siperstein A, Shin J, Berber E, Jin J, Krishnamurthi V, Nasr C, Hong L, Buchberger DS, Woody N, Koyfman SA, Geiger JL.
    JAMA Otolaryngol Head Neck Surg; 2023 Jan 01; 149(1):79-86. PubMed ID: 36454559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.